50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA less than the lower limit of quantification (LLOQ) 24 weeks off all ...

A new device out of LSU can detect where cancer cells end and healthy tissues begin. Here's what it means for health outcomes ...

HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved functional ...

Violence alcohol - Nora de Bode considers a new review on the national and regional prevalence of interpersonal violence from ...

Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Researchers have demonstrated that cannabinol (CBN), a compound found in aged cannabis, improves sleep in rats.

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.